Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Database
Language
Document Type
Year range
1.
BMJ Case Rep ; 15(9)2022 Sep 09.
Article in English | MEDLINE | ID: covidwho-2019954

ABSTRACT

Deep neck space infections (DNSIs) are challenging to diagnose and manage. A female ex-smoker presented with difficulty breathing and chest pain. She was initially treated for exacerbation of emphysema with intravenous antibiotics. The ear, nose and throat team were later asked to review the patient for left submandibular swelling and odynophagia. CT of the neck was performed 10 days later, due to limited availability during COVID-19. It showed an extensive retropharyngeal collection from the level of the vallecula to just above the carina. Normally, a DNSI extending to the mediastinum would require prompt surgical management. However, the patient was clinically well once imaged, so the abscess was managed conservatively with intravenous antibiotics.


Subject(s)
COVID-19 , Mediastinum , Anti-Bacterial Agents/therapeutic use , COVID-19/therapy , Chest Pain/drug therapy , Female , Humans , Mediastinum/diagnostic imaging , Neck/diagnostic imaging
2.
JAAD Int ; 5: 11-18, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1336630

ABSTRACT

BACKGROUND: The cutaneous manifestations of COVID-19 may be useful disease markers and prognostic indicators. Recently, postinfectious telogen effluvium and trichodynia have also been reported. OBJECTIVE: To evaluate the presence of trichodynia and telogen effluvium in patients with COVID-19 and describe their characteristics in relation to the other signs and symptoms of the disease. METHODS: Patients with a history of COVID-19 presenting to the clinics of a group of hair experts because of telogen effluvium and/or scalp symptoms were questioned about their hair signs and symptoms in relation to the severity of COVID-19 and associated symptoms. RESULTS: Data from 128 patients were collected. Telogen effluvium was observed in 66.3% of the patients and trichodynia in 58.4%. Trichodynia was associated with telogen effluvium in 42.4% of the cases and anosmia and ageusia in 66.1% and 44.1% of the cases, respectively. In majority (62.5%) of the patients, the hair signs and symptoms started within the first month after COVID-19 diagnosis, and in 47.8% of the patients, these started after 12 weeks or more. LIMITATIONS: The recruitment of patients in specialized hair clinics, lack of a control group, and lack of recording of patient comorbidities. CONCLUSION: The severity of postviral telogen effluvium observed in patients with a history of COVID-19 infection may be influenced by COVID-19 severity. We identified early-onset (<4 weeks) and late-onset (>12 weeks) telogen effluvium.

3.
Eur Arch Otorhinolaryngol ; 278(2): 573-576, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-893274

ABSTRACT

BACKGROUND: Otolaryngologists are faced with concerning challenges since the onset of the coronavirus disease (COVID-19) pandemic due to significant risk of occupational infection. Transmission can happen during intraoperative exposure to viral particles carried by droplets or aerosols. Endoscopic sinus and skull base surgery are notable for causing aerosolisation, putting healthcare staff at substantial risk. METHOD: We describe the creation of a tight-seal tent from a microscope drape covering the operative field and the operator's hands with the aim to contain aerosols during transnasal endoscopic surgery. CONCLUSION: The microscope drape technique is a simple barrier measure that could potentially improve safety during endoscopic procedures.


Subject(s)
COVID-19 , Child , Endoscopy , Humans , Pandemics , SARS-CoV-2 , Skull Base/surgery
SELECTION OF CITATIONS
SEARCH DETAIL